Novel insights into the role of hypoxia‑inducible factor‑1 in the pathogenesis of human post‑intubation tracheal stenosis

Cai,Zhigang; Li,Haitao; Zhang,Hefang; Han,Shuo; An,Ruijin; Yan,Xixin

doi:10.3892/mmr.2013.1595

Novel insights into the role of hypoxia‑inducible factor‑1 in the pathogenesis of human post‑intubation tracheal stenosis

Authors:
- Zhigang Cai
- Haitao Li
- Hefang Zhang
- Shuo Han
- Ruijin An
- Xixin Yan
View Affiliations

Affiliations: Department of Respiratory Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, Department of Endocrinology, The Traditional Chinese Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China, Department of Anatomy, Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China
Published online on: July 22, 2013 https://doi.org/10.3892/mmr.2013.1595
Pages: 903-908

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypoxia is an important mechanism involved in dermal scar formation. Post‑intubation tracheal stenosis (PTS) has similar pathological characteristics and formation mechanisms to skin hypertrophic scars. Hypoxia‑inducible factor‑1α (HIF‑1α) is a nuclear transcription factor that facilitates the adaptation of human cells to compromised oxygen tension under hypoxic conditions. The aim of this study was to investigate whether hypoxia and HIF‑1α were involved in PTS. In the first part of our study, we observed the effects of tracheal mucosal pressure exerted by the endotracheal tube cuff and duration of intubation on tracheal stenosis using prospective methods. In the second part of our study, 24 patients were divided into three groups, according to the characteristics observed using bronchoscopy: granulation phase group, proliferative phase group and mature phase group. Tissues showing dysplasia were obtained using bronchoscopy forceps, and western blotting was performed to detect the protein expression of HIF‑1α and its target genes, including vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and transforming growth factor (TGF)‑β. In experiment one, we observed that the tracheal mucosal pressure exerted by the endotracheal tube cuff in the PTS group was significantly higher compared with that in the group without PTS, and the duration of intubation was longer compared with that in the group without PTS (P<0.05). In experiment two, we observed that the expression of HIF‑1α was highest in the granulation phase, showed a decrease in the proliferative phase and in the mature phase was significantly reduced compared with the other two phases. The results were similar for VEGF and bFGF. TGF‑β protein expression was highest in the proliferative phase, significantly reduced in the mature phase and the same trends were observed for collagen type Ⅰ and III, and α‑smooth muscle actin. HIF‑1α is involved in the pathogenesis of PTS and may be a potential key regulator in the initiation and facilitation of this process.

View Figures

View References

1	Freitag L, Ernst A, Unger M, Kovitz K and Marquette CH: A proposed classification system of central airway stenosis. Eur Respir J. 30:7–12. 2007. View Article : Google Scholar : PubMed/NCBI
2	Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol. 214:199–210. 2008. View Article : Google Scholar
3	Dohar JE, Klein EC, Betsch JL, et al: Acquired subglottic stenosis-depth and not extent of the insult is key. Int J Pediatr Otorhinolaryngol. 46:159–170. 1998. View Article : Google Scholar : PubMed/NCBI
4	Corrêa Reis JG, Takiya CM, Lima Carvalho A, et al: Myofibroblast persistence and collagen type I accumulation in the human stenotictrachea. Head Neck. 34:1283–1293. 2012.PubMed/NCBI
5	Knowlson GT and Bassett HF: The pressures exerted on the trachea by endotracheal inflatable cuffs. Br J Anaesth. 42:834–837. 1970. View Article : Google Scholar : PubMed/NCBI
6	Cooper JD and Grillo HC: The evolution of tracheal injury due to ventilatory assistance through cuffed tubes: a pathologic study. Ann Surg. 169:334–348. 1969. View Article : Google Scholar : PubMed/NCBI
7	Jiang BH, Zheng JZ, Leung SW, Roe R and Semenza GL: Transactivation and inhibitory domains of hypoxia-inducible factor 1α. Modulation of transcriptional activity by oxygen tension. J Biol Chem. 272:19253–19260. 1997.
8	Ohh M, Park CW, Ivan M, et al: Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat Cell Biol. 2:423–427. 2000.PubMed/NCBI
9	Maxwell PH, Wiesener MS, Chang GW, et al: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:271–275. 1999. View Article : Google Scholar : PubMed/NCBI
10	Masson N, Willam C, Maxwell PH, Pugh CW and Ratcliffe PJ: Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J. 20:5197–5206. 2001.
11	Semenza GL: Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol. 19:12–16. 2009. View Article : Google Scholar : PubMed/NCBI
12	Norman JT, Clark IM and Garcia PL: Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int. 58:2351–2366. 2000. View Article : Google Scholar : PubMed/NCBI
13	Basu RK, Hubchak S, Hayashida T, Runyan CE, Schumacker PT and Schnaper HW: Interdependence of HIF-1α and TGF-β/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression. Am J Physiol Renal Physiol. 300:F898–F905. 2011.
14	Clancy RM, Zheng P, O’Mahony M, et al: Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: implications for progression to scarring in autoimmune-associated congenital heart block. Arthritis Rheum. 56:4120–4131. 2007. View Article : Google Scholar
15	Higgins DF, Kimura K, Bernhardt WM, et al: Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 117:3810–3820. 2007.PubMed/NCBI
16	Nordgren IK and Tavassoli A: Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor. Chem Soc Rev. 40:4307–4317. 2011. View Article : Google Scholar : PubMed/NCBI
17	Scheid A, Wenger RH, Christina H, et al: Hypoxia-regulated gene expression in fetal wound regeneration and adult wound repair. Pediatr Surg Int. 16:232–236. 2000. View Article : Google Scholar : PubMed/NCBI
18	Hiroi M, Mori K, Sakaeda Y, et al: STAT1 represses hypoxia-inducible factor-1-mediated transcription. Biochem Biophys Res Commun. 387:806–810. 2009. View Article : Google Scholar : PubMed/NCBI
19	Sidgwick GP and Bayat A: Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol. 26:141–152. 2012. View Article : Google Scholar : PubMed/NCBI
20	Friedman DW, Boyd CD, Mackenzie JW, Norton P, Olson RM and Deak SB: Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res. 55:214–222. 1993. View Article : Google Scholar : PubMed/NCBI
21	Bellon G, Moreau M, Cam YJ, et al: Modifications of collagens in the course of inflammatory tracheal stenoses. Ann Otol Rhinol Laryngol. 94:403–408. 1985.PubMed/NCBI
22	Doolin EJ, Tsuno K, Strande LF and Santos MC: Pharmacologic inhibition of collagen in an experimental model of subglottic stenosis. Ann Otol Rhinol Laryngol. 107:275–279. 1998. View Article : Google Scholar : PubMed/NCBI
23	Le AD, Zhang Q, Wu Y, et al: Elevated vascular endothelial growth factor in keloids: relevance to tissue fibrosis. Cells Tissues Organs. 176:87–94. 2004. View Article : Google Scholar : PubMed/NCBI
24	Liu H, Chen JC, Holinger LD and Gonzalez-Crussi F: Histopathologic fundamentals of acquired laryngeal stenosis. Pediatr Pathol Lab Med. 15:655–677. 1995. View Article : Google Scholar : PubMed/NCBI
25	Pokharel RP, Maeda K, Yamamoto T, et al: Expression of vascular endothelial growth factor in exuberant tracheal granulation tissue in children. J Pathol. 188:82–86. 1999. View Article : Google Scholar : PubMed/NCBI
26	Rahbar R, Brown LF, Folkman J, et al: Role of vascular endothelial growth factor A in children with acquired airway stenosis. Ann Otol Rhinol Laryngol. 116:430–435. 2007. View Article : Google Scholar : PubMed/NCBI
27	Wu Y, Zhang Q, Ann DK, et al: Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol. 286:C905–C912. 2004. View Article : Google Scholar : PubMed/NCBI
28	Yang GP, Lim IJ, Phan TT, Lorenz HP and Longaker MT: From scarless fetal wounds to keloids: molecular studies in wound healing. Wound Repair Regen. 11:411–418. 2003. View Article : Google Scholar : PubMed/NCBI
29	Suehiro A, Hirano S, Kishimoto Y, Tateya I, Rousseau B and Ito J: Effects of basic fibroblast growth factor on rat vocal fold fibroblasts. Ann Otol Rhinol Laryngol. 119:690–696. 2010.PubMed/NCBI
30	Barrientos S, Stojadinovic O, Golinko MS, Brem H and Tomic-Canic M: Growth factors and cytokines in wound healing. Wound Repair Regen. 16:585–601. 2008. View Article : Google Scholar : PubMed/NCBI
31	Powers CJ, McLeskey SW and Wellstein A: Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer. 7:165–197. 2000. View Article : Google Scholar : PubMed/NCBI
32	Wagatsuma A, Kotake N and Yamada S: Spatial and temporal expression of hypoxia-inducible factor-1α during myogenesis in vivo and in vitro. Mol Cell Biochem. 347:145–155. 2011.
33	Distler JH, Jüngel A, Pileckyte M, et al: Hypoxia-induced increase in the production of extracellular matri-x proteins in systemic sclerosis. Arthritis Rheum. 56:4203–4215. 2007. View Article : Google Scholar : PubMed/NCBI
34	Sogabe Y, Abe M, Yokoyama Y and Ishikawa O: Basic fibroblast growth factor stimulates human keratinocyte motility by Rac activation. Wound Repair Regen. 14:457–462. 2006. View Article : Google Scholar : PubMed/NCBI
35	Brahimi-Horn C and Pouyssegur J: The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull Cancer. 93:E73–E80. 2006.PubMed/NCBI
36	Chang JH, Han KY and Azar DT: Wound healing fibroblasts modulate corneal angiogenic privilege: interplay of basic fibroblast growth factor and matrix metalloproteinases in corneal angiogenesis. Jpn J Ophthalmol. 54:199–205. 2010. View Article : Google Scholar
37	Bos R, van Diest PJ, de Jong JS, van der Groep P, van der Valk P and van der Wall E: Hypoxia-inducible factor-1α is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology. 46:31–36. 2005.
38	Kottmann RM, Kulkarni AA, Smolnycki KA, et al: Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β. Am J Respir Crit Care Med. 186:740–751. 2012.PubMed/NCBI
39	Distler JH, Jungel A, Pileckyte M, et al: Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum. 56:4203–4215. 2007. View Article : Google Scholar : PubMed/NCBI
40	Leigh JM and Maynard JP: Pressure on the tracheal mucosa from cuffed tubes. Br Med J. 1:1173–1174. 1979. View Article : Google Scholar : PubMed/NCBI
41	Lewis FR Jr, Schiobohm RM and Thomas AN: Prevention of complications from prolonged tracheal intubation. Am J Surg. 135:452–457. 1978. View Article : Google Scholar : PubMed/NCBI
42	Lee JW, Bae SH, Jeong JW, Kim SH and Kim KW: Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions. Exp Mol Med. 36:1–12. 2004.
43	Powis G and Kirkpatrick L: Hypoxia inducible factor-1α as a cancer drug target. Mol Cancer Ther. 3:647–654. 2004.
44	Leask A and Abraham DJ: TGF-β signaling and the fibrotic response. FASEB J. 18:816–827. 2004.
45	Liu W, Wang DR and Cao YL: TGF-β: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther. 4:123–136. 2004.
46	Blobe GC, Schiemann WP and Lodish HF: Role of transforming growth factor β in human disease. N Engl J Med. 342:1350–1358. 2000.
47	Karagiannidis C, Velehorschi V, Obertrifter B, Macha HN, Linder A and Freitag L: High-level expression of matrix-associated transforming growth factor-β1 in benign airway stenosis. Chest. 129:1298–1304. 2006.
48	Higgins DF, Kimura K, Iwano M and Haase VH: Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle. 7:1128–1132. 2008. View Article : Google Scholar : PubMed/NCBI
49	Copple BL: Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-β-dependent mechanisms. Liver Int. 30:669–682. 2010.PubMed/NCBI
50	Chen Z, Zhang D, Yue F, Zheng M, Kovacevic Z and Richardson DR: The iron chelators Dp44mT and DFO inhibit TGF-β-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1). J Biol Chem. 287:17016–17028. 2012.PubMed/NCBI